Similar articles

• [Aberrations of Smad genes in human digestive tract cancers].

  Hagiwara K. Hagiwara K. Tanpakushitsu Kakusan Koso. 2001 Feb;46(2):124-9. Tanpakushitsu Kakusan Koso. 2001. PMID: 11211786 Review. Japanese. No abstract available.
• Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice.

  Taketo MM, Takaku K. Taketo MM, et al. Hum Cell. 2000 Sep;13(3):85-95. Hum Cell. 2000. PMID: 11197776 Review.
• Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.

  Duda DG, Sunamura M, Lefter LP, Furukawa T, Yokoyama T, Yatsuoka T, Abe T, Inoue H, Motoi F, Egawa S, Matsuno S, Horii A. Duda DG, et al. Oncogene. 2003 Oct 9;22(44):6857-64. doi: 10.1038/sj.onc.1206751. Oncogene. 2003. PMID: 14534532
• Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice.

  Redman RS, Katuri V, Tang Y, Dillner A, Mishra B, Mishra L. Redman RS, et al. J Oral Pathol Med. 2005 Jan;34(1):23-9. doi: 10.1111/j.1600-0714.2004.00246.x. J Oral Pathol Med. 2005. PMID: 15610403
• Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.

  Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Maki K, Ogawa S, Chiba S, Mitani K, Hirai H. Imai Y, et al. Oncogene. 2001 Jan 4;20(1):88-96. doi: 10.1038/sj.onc.1204057. Oncogene. 2001. PMID: 11244507